ArticlemedRxiv : the preprint server for health sciences2026
Stakeholder Perspectives on Long-Acting Injectable PrEP and MOUD: A Descriptive Qualitative Study.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Long-acting injectable (LAI) formulations of pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) offer promising new approaches for addressing the intersecting challenges of HIV and opioid use disorder (OUD) in carceral settings. However, successful implementation requires understanding the perspectives of key carceral and community stakeholders. This qualitative study involved 17 semi-structured stakeholder interviews including correctional staff (medical and administrative) and community healthcare providers. Participants were recruited from jails in Washington, DC and surrounding Maryland counties. Interviews were coded using a mixed inductive and deductive methodology, and data were analyzed to identify key themes. Four overarching themes relevant to implementation emerged: (1) The presence of resource barriers, including jail staffing shortages and financial constraints; (2) Challenges administering medications including stigma, medical mistrust, and limited patient knowledge of medications; (3) challenging and restrictive carceral infrastructure; and (4) the importance of care continuity during carceral-to-community transition. Stakeholders emphasized that while LAI PrEP and MOUD could provide critical support to justice-involved individuals, systemic barriers challenged successful implementation and delivery in jail and during community re-entry. Our findings underscore the need for targeted interventions to address the resource, medication, and infrastructure challenges identified. Ensuring sustainable funding, providing staff training and education, improving patient education, addressing stigma, and strengthening community linkages are essential for the successful implementation of LAI PrEP and MOUD in carceral settings. These insights can inform future policies and practices aimed at improving health outcomes for justice-involved populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.